Words of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Eur Urol
.
2015 May;67(5):975.
doi: 10.1016/j.eururo.2014.12.065.
Authors
Zachary S Buchwald
1
,
Jason A Efstathiou
2
Affiliations
1
Saint Louis University, Saint Louis, MO, USA.
2
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jefstathiou@partners.org.
PMID:
25845961
DOI:
10.1016/j.eururo.2014.12.065
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal / therapeutic use*
Female
Humans
Immunotherapy*
Male
Urinary Bladder Neoplasms / therapy*
Substances
Antibodies, Monoclonal